Citigroup
APYX icon

Citigroup’s Apyx Medical APYX Stock Holding History

Citigroup’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.3K Buy
18,989
+3,192
+20% +$12.7K ﹤0.01% 4769
2026
Q1 		$58.3K Sell
15,797
-5,822
-27% -$21.8K ﹤0.01% 4470
2025
Q4 		$75.7K Buy
+21,619
New +$75.4K ﹤0.01% 4434
2023
Q4 		– Sell
-38,277
Closed -$122K – 5684
2023
Q3 		$122K Buy
+38,277
New +$178K ﹤0.01% 3863
2022
Q3 		– Sell
-311
Closed -$2K – 5805
2022
Q2 		$2K Sell
311
-1,309
-81% -$6.72K ﹤0.01% 5852
2022
Q1 		$11K Sell
1,620
-6,309
-80% -$62.1K ﹤0.01% 5467
2021
Q4 		$102K Buy
7,929
+4,440
+127% +$62.1K ﹤0.01% 4718
2021
Q3 		$48K Buy
3,489
+1,944
+126% +$20.4K ﹤0.01% 4751
2021
Q2 		$16K Sell
1,545
-730
-32% -$7.23K ﹤0.01% 5412
2021
Q1 		$22K Sell
2,275
-4,378
-66% -$43.8K ﹤0.01% 5185
2020
Q4 		$48K Buy
6,653
+4,985
+299% +$33K ﹤0.01% 6054
2020
Q3 		$8K Sell
1,668
-2,988
-64% -$14.8K ﹤0.01% 6743
2020
Q2 		$26K Sell
4,656
-4,778
-51% -$19.9K ﹤0.01% 6401
2020
Q1 		$34K Buy
9,434
+2,759
+41% +$18.5K ﹤0.01% 6304
2019
Q4 		$56K Buy
6,675
+5,734
+609% +$41.4K ﹤0.01% 6208
2019
Q3 		$7K Sell
941
-7,670
-89% -$54.4K ﹤0.01% 7203
2019
Q2 		$58K Sell
8,611
-33,967
-80% -$185K ﹤0.01% 6326
2019
Q1 		$269K Buy
+42,578
New +$329K ﹤0.01% 4814
2017
Q2 		– Sell
-1,615
Closed -$4K – 7332
2017
Q1 		$4K Buy
+1,615
New +$5.36K ﹤0.01% 6844
2016
Q2 		– Sell
-97
Closed – – 7055
2016
Q1 		$0 Buy
+97
New +$195 ﹤0.01% 7437
2015
Q2 		– Sell
-38
Closed – – 7499
2015
Q1 		$0 Sell
38
-962
-96% -$3.2K ﹤0.01% 7187
2014
Q4 		$4K Buy
+1,000
New +$3.89K ﹤0.01% 6714
2014
Q1 		– Sell
-900
Closed -$2K – 6986
2013
Q4 		$2K Buy
+900
New +$2.2K ﹤0.01% 6768

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's APYX Position: Q2 2026 in Review

Citigroup increased its Apyx Medical (APYX) stake by 20% in Q2 2026, buying an estimated $12.7K and bringing the position to 18,989 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4769.

Citigroup first reported a position in APYX in Q4 2013 and has held it in 23 quarters since. The position peaked at $269K in Q1 2019. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Citigroup held 18,989 shares of Apyx Medical worth $85.3K as of Q2 2026.
  • Citigroup bought 3,192 Apyx Medical shares in Q2 2026, an estimated $12.7K.
  • Apyx Medical made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4769 holding.
  • Citigroup first reported a position in Apyx Medical in Q4 2013 and has held it in 23 quarters since.
  • Citigroup's Apyx Medical position peaked at $269K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.